Faculty Information |
|
Language | English |
The announcement title | A multicenter phase 2 trial of ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with combination chemotherapy with anti-EGFR antibody: JACCRO CC-16. |
Academic Society name | 2022 ASCO Gastrointestinal Cancers Symposium |
Conference Type | International Society |
Announcement form | Poster presentation |
Presentation Type | General Lecture |
Lecture Type | 一般 |
Publisher and common publisher | Masato Nakamura, Akihito Tsuji, Yoshihiro Okita, Toshihiko Matsumoto, Tamotsu Sagawa, Takanori Watanabe, Kozo Kataoka, Dai Manaka, Kazuhiro Shiraishi, Naoya Akazawa, Tatsuya Okuno, Takaya Shimura, Manabu Shiozawa, Shingo Noura, Yu Sunakawa, Yasuki Akiyama, Hirofumi Ota, Masahiro Takeuchi, Wataru Ichikawa, Masashi Fujii |
Date | 2022/01/22 |
Country | United States |
Venue (city and name of the country) |
San Francisco |
Holding period | 2022/01/20~2022/01/22 |
Society abstract | Journal of Clinical Oncology 40(4),112 2022 |